markers with neovascular age-related macular degeneration (AMD). DESIGN: Cross-
sectional case–control study. PARTICIPANTS: Of the 410 of the≥ 65-year-old community
sample invited to attend, 205 participated (50% response rate). Of the 215 clinic attendees
who were invited to participate, 212 agreed to take part (98% response rate). A diagnosis of
neovascular AMD in at least one eye was made in 193 clinic attendees and 2 of the …